Affiliation:
1. Institute of Systems Neuroscience, Heinrich Heine University Düsseldorf, Düsseldorf 40225, Germany
2. Institute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany
3. Department of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty, RWTH Aachen University, Aachen, Germany
4. JARA-BRAIN, Jülich-Aachen Research Alliance, Jülich, Germany
5. Institute for Anatomy I, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
6. C. & O. Vogt Institute for Brain Research, Heinrich Heine University, Düsseldorf, Germany
7. GIGA-CRC In vivo Imaging, University of Liege, Liege, Belgium
Abstract
Abstract
The hippocampus is a plastic region and highly susceptible to ageing and dementia. Previous studies explicitly imposed a priori models of hippocampus when investigating ageing and dementia-specific atrophy but led to inconsistent results. Consequently, the basic question of whether macrostructural changes follow a cytoarchitectonic or functional organization across the adult lifespan and in age-related neurodegenerative disease remained open. The aim of this cross-sectional study was to identify the spatial pattern of hippocampus differentiation based on structural covariance with a data-driven approach across structural MRI data of large cohorts (n = 2594). We examined the pattern of structural covariance of hippocampus voxels in young, middle-aged, elderly, mild cognitive impairment and dementia disease samples by applying a clustering algorithm revealing differentiation in structural covariance within the hippocampus. In all the healthy and in the mild cognitive impaired participants, the hippocampus was robustly divided into anterior, lateral and medial subregions reminiscent of cytoarchitectonic division. In contrast, in dementia patients, the pattern of subdivision was closer to known functional differentiation into an anterior, body and tail subregions. These results not only contribute to a better understanding of co-plasticity and co-atrophy in the hippocampus across the lifespan and in dementia, but also provide robust data-driven spatial representations (i.e. maps) for structural studies.
Funder
Alzheimer's Disease Neuroimaging Initiative
ADNI
National Institutes of Health
DOD ADNI
Department of Defense
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
Alzheimer’s Association
Alzheimer’s Drug Discovery Foundation
Araclon Biotech
BioClinica, Inc
Biogen
Bristol-Myers Squibb Company
CereSpir, Inc
Cogstate
Eisai Inc
Elan Pharmaceuticals, Inc
Eli Lilly and Company
EuroImmun
F Hoffmann-La Roche Ltd
Genentech, Inc
Fujirebio
GE Healthcare; IXICO Ltd
Janssen Alzheimer Immunotherapy Research and Development, LLC
Johnson and Johnson Pharmaceutical Research and Development LLC
Lumosity
Lundbeck
Merck and Co, Inc
Meso Scale Diagnostics, LLC
NeuroRx Research
Neurotrack Technologies
Novartis Pharmaceuticals Corporation; Pfizer Inc
Piramal Imageng
Servier
Takeda Pharmaceutical Company
Transition Therapeutics.
The Canadian Institutes of Health Research
Northern California Institute for Research and Education
University of Southern California
UK Biotechnology and Biological Sciences Research Council
UK Medical Research Council and University of Cambridge, UK
Deutsche Forschungsgemeinschaft
Helmholtz-Gemeinschaft
Horizon 2020 Framework Programme
Publisher
Oxford University Press (OUP)